Navigation Links
New drug proven to tackle Type 2 Diabetes

A new drug called Rosiglitazone capable of controlling Type 2 diabetes has been given the green signal by researchers, Researchers// content that this drug is capable of reported in The Lancet ,a renounced British medical journal . Researchers content that this drug is capable of reducing Type 2 Diabetes by 60%.

The results of a 3 year long study named DREAM(for Diabetes Reduction Approaches with Medication )conducted at Royal Victoria Hospital led by endocrinologist Jean-Francois Yale have shown that in every thousand cases of “pre-diabetes” treated with Rosiglitazone,144 new cases were prevented. The drug exhibited a capability to bring down blood sugar levels to normal. This 25 million dollar study which was funded by 3 drug companies and Canadian Institutes of Health Research studied 5,000 patients recruited from over 21 countries. Canada itself has a staggering 2 million diabetics currently and is expected to cross 3 million by year 2010.

Such a breakthrough would immensely benefit individuals with a strong history of Diabetes running in the family, or were either parent or both are already known diabetics. However it has to be kept in mind that predominantly it is only a well balanced diet and regular exercise that have been proven to pay rich dividends in controlling the late onset type of diabetes, as proven in research studies. Though currently rosiglitazone is being used only as a second line treatment for diabetics, it may soon be used as a front line therapy for nearly 8% of people with high blood sugar world wide.

Rosiglitazone is still not proven in its efficacy to stall onset of Diabetes in those who fall in the high risk group or if there could be a relapse of diabetes if it is withdrawn from a patient. Nearly 2 million Canadians are diabetic. The Canadian Diabetes Association predicts that number will rise to 3 million by 2010.

It's not known yet whether the drug prevents or delays diabetes or whether i
'"/>




Page: 1 2

Related medicine news :

1. TELITHROMYCIN - the proven effective new drug for cap
2. Partial-Breast Irradiation an Unproven Therapy
3. The Use of Radio Frequency Identification ( RFID) to tackle the growing menace of counterfeit drugs
4. Guidelines to tackle bird flu pandemic
5. U.S. unprepared to tackle bird flu
6. Meeting to tackle Chikungunya
7. AIDS to be tackled through Computer Games
8. Is Diabetes the Leading Cause of Kidney Failure in India
9. Diabetes and Depression often go hand-in-hand
10. Thirty minutes of work up per day reduces the risk of Diabetes
11. Diabetes on the rise

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New drug proven tackle Type Diabetes

(Date:12/2/2009)...K, Dec. 2 Reportlinker.com announc...in its catalogue: ,, Sterilization Technologi...er.com/p0166820/Sterilization-Technologies-The-US-...s of capital equipment to the sterilization indust...nual growth rate for 2009-2014. ,, Explains how...
(Date:12/2/2009)...K, Dec. 2 Reportlinker.com announc...in its catalogue: ,, Antibiotic Resistance and...ttp://www.reportlinker.com/p0166825/Antibiotic-Res....html ,, Provide an in-depth review of the glo...ics technologies ,, Offer an analysis of antibi...
(Date:12/2/2009)...plasty within 90 minutes of hospital arrival, stud... News) -- A nationwide program to get faster treat... attack has dramatically reduced the time between ...More than three-quarters of people with STEMI hear...ogram pattern that shows major blockage of a heart...
(Date:12/2/2009)...lable, many more to come, NIH director says, , ...hirteen stem cell lines have been added to the poo...arch, and many more such lines will soon be made a...y. , These are the first additional embryonic s... U.S. National Institutes of Health (NIH) since Pr...
(Date:12/2/2009)... New Directors Represent Diverse Healthcare Stake...Newswire/ -- The membership of the National Qualit...d of Directors and reappointed four current Board ...nge of healthcare stakeholders, including consumer... and community healthcare. ,, The newly electe...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 2Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 3Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 4Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 5Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 6Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 7Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 8Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 9Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 10Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 11Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 12Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 13Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 2Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 3Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 4Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 5Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 6Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 7Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 8Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 9Health News:Heart Attack Treatment Speeds Up Nationwide 2Health News:Heart Attack Treatment Speeds Up Nationwide 3Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 2Health News:U.S. Approves New Stem Cell Lines for Publicly Funded Research 3Health News:National Quality Forum Members Elect Nine Directors to Board 2Health News:National Quality Forum Members Elect Nine Directors to Board 3
...Nov. 7 /PRNewswire-FirstCall/ - Labopharm Inc. (TS...R. Selisker has been appointed to,the Board of Dir...by the,resignation of James S. Scibetta, who has s...ountant, will bring,senior financial advisory expe...
...E, Md., Nov. 7 EntreMed, Inc.,(Nasdaq: ENMD ) a ...herapeutics for the treatment of cancer and inflam...s, President and Chief Executive Officer,will pres...l in New York, NY. Mr. Burns, presentation is sche...
...ember 7 Misys (LSE: MSY), the,global application ...rade,Processing product, for the second year in a ...solution, Misys Confirmation Matching Service,(CMS...echnology,s readers were asked to vote on what the...
...utritional Supplements Offers Tips on Expressing G... 7 Schiff(R) Nutrition,International, one of the ...al supplement industry for more than 70 years, has...dults, who,are changing the stereotypical idea of ...
... Marathon Health, a leading provide...y solutions, announced today that Accellent, a lea...ected Marathon Health to provide onsite primary ca...around the United States. , ...
... Two-Hour Minimally Invasive Outpat...only a 10 Day Recovery Time - Results Last Up to 1... (PRWEB) November 7, 2008 -- Thanksgiving is less ...e at this year,s holiday feast and December partie...
Other Medicine News:Health News:EntreMed to Present at the Rodman and Renshaw 10th Annual Healthcare Conference 2Health News:Misys Wins 'Best Trade Processing Product' Accolade in European Banking Technology Readers' Choice Awards 2Health News:Schiff(R) Nutrition International Declares November 'Give Thanks for Grandparents Month' 2Health News:Accellent and Marathon Health Partner for Employee Health. Employee Health Status and Costs Drive New Health Strategy 2Health News:Accellent and Marathon Health Partner for Employee Health. Employee Health Status and Costs Drive New Health Strategy 3Health News:Accellent and Marathon Health Partner for Employee Health. Employee Health Status and Costs Drive New Health Strategy 4Health News:There's Still Time to Ensure Your Turkey Neck Doesn't Make an Appearance at Thanksgiving Dinner Thanks to Innovative Tuliplift 2Health News:There's Still Time to Ensure Your Turkey Neck Doesn't Make an Appearance at Thanksgiving Dinner Thanks to Innovative Tuliplift 3Health News:There's Still Time to Ensure Your Turkey Neck Doesn't Make an Appearance at Thanksgiving Dinner Thanks to Innovative Tuliplift 4
(Date:12/2/2009)... , WESTON, Fla., Dec. 2 /PRNewswire-FirstCall...heets: ASFX) (the Company), announces that the Dis... home needle destruction device (NDD), is in its f...esigned to fill the current demand for home inject...ng from the recent passing of the SB 486 which r...
(Date:12/2/2009)..., WALTHAM, Mass. and NEW YORK, Dec. 2 /PRNewswir...mex: ILI ) and NYU Langone Medical Center announc...n with Duke University on the genetics of osteoart...e First" version of the Annals of Rheumatic Diseas...idpdf/ard.2009.113043v1.pdf . Results from the...
(Date:12/2/2009)..., WALTHAM, Mass., Dec. 2 Decisi...and advisory firms for pharmaceutical and healthca...stablished branded atypical antipsychotics will ca... $6.3 billion in 2008 to $5.2 billion in 2013 in t...he United Kingdom and Japan. ,, The new Pharmac...
Breaking Medicine Technology:World's Only FDA Approved Home Needle Destruction Device is in Production 2World's Only FDA Approved Home Needle Destruction Device is in Production 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013 2Caltech chemists say antibody surrogates are just a click away 51252 1Caltech chemists say antibody surrogates are just a click away 51252 2Caltech chemists say antibody surrogates are just a click away 51252 3AACR applauds nomination of Francis S Collins M D Ph D to be the new NIH director 9195 1Calling All Runners 3A Join the Fight Against Cancer 51247 1Calling All Runners 3A Join the Fight Against Cancer 51247 2
...ATEO, Calif., July 11 NeurogesX, Inc.,(Nasdaq: N...loping and,commercializing novel pain management t...clinical trial (study C203) of NGX-1998. The produ...sed liquid formulation,designed to deliver a local... The randomized, single-blind Phase 1 trial is des...
...ETON, N.J., July 10 Medarex, Inc.,(Nasdaq: MEDX ...y,s,strategy, strength in research discovery and a...s Medarex is engaged in for creating long-term val...and future antibody programs,as well as updated 20...President and CEO, Howard H. Pien, and other membe...
Other Medicine Technology:NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation 2NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation 3NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation 4Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 2Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 3Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 4Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 5Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 6
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
Medicine Products: